• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Metals
    Tech
    Life Science
    Genetics Market
    Genetics News
    Genetics Stocks
    • Genetics Market
    • Genetics News
    • Genetics Stocks

    Fulgent Genetics Reports Fourth Quarter and Full Year 2017 Financial Results

    Gabrielle Lakusta
    Mar. 01, 2018 09:25AM PST
    Genetics Investing

    Fulgent Genetics (NASDAQ:FLGT) announced financial results for its fourth quarter and full year ended December 31, 2017. As quoted in the press release: Fourth quarter revenue was $4.3 million, a decrease of 27% year over year from $5.9 million in the fourth quarter of 2016. For the full year of 2017, revenue was $18.7 million, …

    Fulgent Genetics (NASDAQ:FLGT) announced financial results for its fourth quarter and full year ended December 31, 2017.

    As quoted in the press release:

    Fourth quarter revenue was $4.3 million, a decrease of 27% year over year from $5.9 million in the fourth quarter of 2016. For the full year of 2017, revenue was $18.7 million, compared to $18.3 million in the prior year. GAAP loss for the fourth quarter of 2017 was $1.8 million, or $0.10 per share, and non-GAAP loss was $1.0 million, or $0.06 per share. GAAP loss for the full year 2017 was $2.7 million, or $0.15 per share, and non-GAAP loss was $459,000, or $0.03 per share.

    Click here to read the full press release.

    fulgent geneticsfinancial results
    The Conversation (0)

    Go Deeper

    AI Powered
    NASDAQ:MYGN

    Myriad Genetics Tumbles on Fiscal Q4 and 2019 Results

    Ultragenyx Reports First Quarter 2018 Financial Results and Corporate Update

    Latest News

    Outlook Reports world

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Genetics Investing Stocks

    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES